From Proof of Concept to First-Cycle Approval: Reducing Drug Development Risk Through Effective Meetings with FDA
This article was originally published in RPM Report
Executive Summary
Effective FDA meetings are a key success factor for speeding up pharmaceutical development, but they must be properly managed to maximize their benefits.